These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24846534)

  • 1. Progression from metabolically benign to at-risk obesity in perimenopausal women: a longitudinal analysis of study of women across the nation (SWAN).
    Khan UI; Wang D; Karvonen-Gutierrez CA; Khalil N; Ylitalo KR; Santoro N
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2516-25. PubMed ID: 24846534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN).
    Khan UI; Wang D; Thurston RC; Sowers M; Sutton-Tyrrell K; Matthews KA; Barinas-Mitchell E; Wildman RP
    Atherosclerosis; 2011 Jul; 217(1):179-86. PubMed ID: 21310415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.
    Hashimoto Y; Hamaguchi M; Fukuda T; Ohbora A; Kojima T; Fukui M
    Endocrine; 2017 Jul; 57(1):89-97. PubMed ID: 28508194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of body mass index and its long-term changes with cardiometabolic diseases: A nationwide twin study.
    Guo J; Li X; Yang R; Marseglia A; Dove A; Johnell K; Xu W
    Clin Nutr; 2021 Nov; 40(11):5467-5474. PubMed ID: 34656027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study.
    Ogorodnikova AD; Khan UI; McGinn AP; Zeb I; Budoff MJ; Harman SM; Miller VM; Brinton EA; Manson JE; Hodis HN; Merriam GR; Cedars MI; Taylor HS; Naftolin F; Lobo RA; Santoro N; Wildman RP
    Obesity (Silver Spring); 2013 Aug; 21(8):1726-33. PubMed ID: 23670850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women.
    Schmiegelow MD; Hedlin H; Mackey RH; Martin LW; Vitolins MZ; Stefanick ML; Perez MV; Allison M; Hlatky MA
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25994446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study.
    Gutiérrez-Repiso C; Soriguer F; Rojo-Martínez G; García-Fuentes E; Valdés S; Goday A; Calle-Pascual A; López-Alba A; Castell C; Menéndez E; Bordiú E; Delgado E; Ortega E; Pascual-Manich G; Urrutia I; Mora-Peces I; Vendrell J; Vázquez JA; Franch J; Girbés J; Castaño L; Serrano-Ríos M; Martínez-Larrad MT; Catalá M; Carmena R; Gomis R; Casamitjana R; Gaztambide S
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):947-55. PubMed ID: 24984822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study.
    Bradshaw PT; Reynolds KR; Wagenknecht LE; Ndumele CE; Stevens J
    Int J Obes (Lond); 2018 Mar; 42(3):295-301. PubMed ID: 28990591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study.
    Wildman RP; Kaplan R; Manson JE; Rajkovic A; Connelly SA; Mackey RH; Tinker LF; Curb JD; Eaton CB; Wassertheil-Smoller S
    Obesity (Silver Spring); 2011 Jul; 19(7):1482-91. PubMed ID: 21233809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).
    Wildman RP; Muntner P; Reynolds K; McGinn AP; Rajpathak S; Wylie-Rosett J; Sowers MR
    Arch Intern Med; 2008 Aug; 168(15):1617-24. PubMed ID: 18695075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does metabolic health in overweight and obesity persist? - Individual variation and cardiovascular mortality over two decades.
    Kaur A; Johnston DG; Godsland IF
    Eur J Endocrinol; 2016 Aug; 175(2):133-43. PubMed ID: 27412654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index at Accession and Incident Cardiometabolic Risk Factors in US Army Soldiers, 2001-2011.
    Hruby A; Bulathsinhala L; McKinnon CJ; Hill OT; Montain SJ; Young AJ; Smith TJ
    PLoS One; 2017; 12(1):e0170144. PubMed ID: 28095509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations of Metabolically Healthy and Unhealthy Obesity to Digital Vascular Function in Three Community-Based Cohorts: A Meta-Analysis.
    Brant LC; Wang N; Ojeda FM; LaValley M; Barreto SM; Benjamin EJ; Mitchell GF; Vasan RS; Palmisano JN; Münzel T; Blankenberg S; Wild PS; Zeller T; Ribeiro AL; Schnabel RB; Hamburg NM
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents.
    Rizzo AC; Goldberg TB; Silva CC; Kurokawa CS; Nunes HR; Corrente JE
    Nutr J; 2013 Jan; 12():19. PubMed ID: 23363783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis.
    Kramer CK; Zinman B; Retnakaran R
    Ann Intern Med; 2013 Dec; 159(11):758-69. PubMed ID: 24297192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents.
    Lambert M; Delvin EE; Levy E; O'Loughlin J; Paradis G; Barnett T; McGrath JJ
    Can J Cardiol; 2008 Jul; 24(7):575-83. PubMed ID: 18612501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of body mass index to metabolic syndrome risk factors in Syrian adolescents.
    Al-Bachir M; Bakir MA
    J Med Case Rep; 2017 Jun; 11(1):170. PubMed ID: 28646923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormetic effect of triiodothyronine in metabolically healthy obese persons.
    Jun JE; Kim TH; Lee SE; Lee YB; Jee JH; Bae JC; Jin SM; Hur KY; Kim JH; Kim SW; Chung JH; Min YK; Lee MK
    Endocrine; 2017 Sep; 57(3):418-427. PubMed ID: 28726184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.